3 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Lawrence Einhorn: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Platinum Study Comparison Group Questionnaire - Testicular Neoplasms | Completed | Lawrence Einhorn | 102 | 2015-05-01 | 2020-04-08 | |
| Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors Fosaprepitant, Dexamethasone, 5HT3 - Chemotherapy-Induced Nausea and Vomiting | Phase 2 | Completed | Lawrence Einhorn | 65 | 2013-01-01 | 2016-05-25 |
| Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies Amrubicin, Cyclophosphamide - Lung Cancer | Phase 1 | Completed | Lawrence Einhorn | 36 | 2009-03-01 | 2015-12-23 |
Testicular Neoplasms (2) · Lung Neoplasms (1) · Neoplasms, Germ Cell and Embryonal (1) · Neurotoxicity Syndromes (1) · Ototoxicity (1) · Vomiting (1)
Cyclophosphamide (1) · Dexamethasone (1) · Surveys and Questionnaires (1) · amrubicin (1) · fosaprepitant (1)
United States (3)